A 52-year-old woman presents to the outpatient clinic with a 3-month history of fatigue, bone pain, and polyuria. Serum calcium is 11.2 mg/dL (normal 8.5–10.5), phosphate 2.8 mg/dL (normal 2.5–4.5), and PTH 156 pg/mL (normal 15–65). Alkaline phosphatase is elevated at 92 U/L. Renal function is normal. What is the most appropriate next step in management?

Explanation

## Clinical Context This patient has biochemical and clinical features of **primary hyperparathyroidism (PHP)**: - Elevated serum calcium (hypercalcemia) - Elevated PTH (inappropriately high for the degree of hypercalcemia) - Low-normal phosphate (PTH suppresses renal phosphate reabsorption) - Elevated alkaline phosphatase (bone turnover marker) - Symptoms: fatigue, bone pain (osteitis fibrosa cystica), polyuria (hypercalcemia-induced nephrogenic diabetes insipidus) ## Diagnostic Algorithm for Primary Hyperparathyroidism ```mermaid flowchart TD A[Elevated Ca + elevated PTH]:::outcome --> B[Confirm diagnosis with repeat labs]:::action B --> C{Symptomatic or severe hypercalcemia?}:::decision C -->|Yes or Ca > 11.5| D[Localization imaging before surgery]:::action C -->|No, mild, asymptomatic| E[Conservative management with monitoring]:::action D --> F[Ultrasound or Sestamibi scan]:::action F --> G[Parathyroidectomy]:::action E --> H[Annual biochemistry + DEXA scan]:::action ``` ## Why Parathyroid Imaging Is the Next Step **Key Point:** Once primary hyperparathyroidism is biochemically confirmed, the next step in a **symptomatic patient** is **localization imaging** to identify the site of the adenoma (or hyperplasia) before surgical intervention. **High-Yield:** Imaging options include: - **Sestamibi (99mTc-sestamibi) scan** — gold standard for adenoma localization; sensitivity ~90% for single adenomas - **Parathyroid ultrasound** — operator-dependent but useful as first-line; sensitivity ~60–80% - **CT or MRI** — reserved for reoperative cases or multiglandular disease **Clinical Pearl:** This patient is **symptomatic** (bone pain, fatigue, polyuria) and has **biochemically confirmed PHP**, making her a **surgical candidate**. Imaging to localize the adenoma is essential before parathyroidectomy. ## Why Other Options Are Incorrect | Option | Why Wrong | |--------|----------| | Calcitriol supplementation | Calcitriol (active vitamin D) would **worsen hypercalcemia** in PHP by increasing intestinal calcium absorption. Contraindicated. | | Low-calcium diet + fluid intake | Dietary restriction and hydration are supportive measures for **acute symptomatic hypercalcemia** (e.g., malignancy-related), not definitive management of PHP. | | Bisphosphonate | Bisphosphonates reduce bone resorption and lower serum calcium but do **not address the underlying PTH excess**. Used only in severe hypercalcemia or when surgery is not an option. | **Warning:** Do not confuse primary hyperparathyroidism (PTH-mediated) with secondary/tertiary hyperparathyroidism (where PTH is a physiologic response to low calcium or chronic kidney disease). In PHP, the parathyroid gland is autonomous and must be removed.